Bryce Point Capital LLC Purchases New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bryce Point Capital LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 939 shares of the healthcare conglomerate's stock, valued at approximately $475,000.

Other hedge funds have also recently bought and sold shares of the company. Howard Capital Management Group LLC acquired a new position in UnitedHealth Group during the third quarter valued at $341,000. Principal Financial Group Inc. increased its stake in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares during the period. Jacobs Levy Equity Management Inc. acquired a new stake in UnitedHealth Group in the 3rd quarter worth $319,000. Texas Capital Bank Wealth Management Services Inc lifted its position in UnitedHealth Group by 1.5% in the third quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,370 shares of the healthcare conglomerate's stock worth $9,571,000 after purchasing an additional 236 shares during the period. Finally, Temasek Holdings Private Ltd boosted its holdings in UnitedHealth Group by 137.6% during the third quarter. Temasek Holdings Private Ltd now owns 161,656 shares of the healthcare conglomerate's stock valued at $94,517,000 after purchasing an additional 93,618 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $15.50 during mid-day trading on Friday, reaching $524.94. 9,914,705 shares of the stock traded hands, compared to its average volume of 4,256,040. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $480.17 billion, a PE ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. The business has a 50-day moving average of $509.24 and a 200 day moving average of $542.37. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter last year, the firm earned $5.83 earnings per share. The firm's quarterly revenue was up 6.8% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.60%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research note on Thursday, January 2nd. KeyCorp reissued an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.